Vol. 1 No. 2 (2025), Articles
Vol. 1 No. 2 (2025)

PARKINSON’S DISEASE: MITOCHONDRIAL DYSFUNCTION, PROTEIN MISFOLDING AND NEUROINFLAMMATION AS BIOMARKER PATHWAYS

Articles
Published 2025-11-09
Fayzullakhujayev Khasankhon Jaloliddin ogli
Tashkent State Medical University
Matmurodov Rustam Jumanazarovich
Tashkent State Medical University
Rakhimova Shakhnozakhon Mukhiddin qizi
Kimyo International University in Tashkent
PDF

Keywords

Parkinson’s disease, mitochondrial dysfunction, protein misfolding, neuroinflammation, biomarkers, α-synuclein, tau.

Abstract

To explore the relationship between mitochondrial dysfunction, protein misfolding, and neuroinflammatory markers in patients with Parkinson’s disease (PD) and to assess their potential as diagnostic biomarkers.

PDF

References

Schapira, A. H. V., & Gegg, M. (2011). Mitochondrial contribution to Parkinson’s disease pathogenesis. Parkinsonism & Related Disorders, 17(Suppl 1), S47–S50. https://doi.org/10.1016/S1353-8020(10)70013-6

2. Exner, N., Lutz, A. K., Haass, C., & Winklhofer, K. F. (2012). Mitochondrial dysfunction in Parkinson’s disease: molecular mechanisms and pathophysiological consequences. The EMBO Journal, 31(14), 3038–3062. https://doi.org/10.1038/emboj.2012.170

3. Schapira, A. H. V. (2010). Mitochondrial diseases. The Lancet, 375(9710), 940–951. https://doi.org/10.1016/S0140-6736(09)61935-7

4. Bellucci, A., Navarria, L., & Casella, L. (2012). Alpha-synuclein synaptic pathology in Parkinson's disease. Parkinson’s Disease, 2012, 1–12. https://doi.org/10.1155/2012/920105

5. Goedert, M., Masuda-Suzukake, M., & Falcon, B. (2017). Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration. Brain, 140(2), 266–278. https://doi.org/10.1093/brain/aww153

6. Tansey, M. G., & Goldberg, M. S. (2010). Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention. Neurobiology of Disease, 37(3), 510–518. https://doi.org/10.1016/j.nbd.2009.11.004

7. Kalia, L. V., & Lang, A. E. (2015). Parkinson’s disease. The Lancet, 386(9996), 896–912. https://doi.org/10.1016/S0140-6736(14)61393-3